| Cohort A | Cohort B | ||
---|---|---|---|---|
Characteristic | Â | % of patients | Â | % of patients |
Total patients, n | 96 | Â | 36 | Â |
Age at diagnosis, years | Â | Â | Â | Â |
Mean | 58 | Â | 59 | Â |
Range | 30-90 | Â | 35-80 | Â |
Menopause, n | 68 | 71 | - | Â |
Histotype, n | Â | Â | Â | Â |
Infiltrating ductal cancer | 73 | 76 | 21 | 58 |
Infiltrating lobular cancer | 10 | 10 | 1 | 3 |
Others | 13a | 14 | 14 | 39 |
Stage, n | Â | Â | Â | Â |
I | 34 | 35 | 1 | 3 |
II | 55 | 57 | 20 | 56 |
III/IV | 7 | 7 | 11 | 31 |
Unknown | 0 | Â | 4 | 10 |
Lymph node status, n | Â | Â | Â | Â |
Positive | 54 | 56 | 19 | 53 |
Negative | 38 | 40 | 17 | 47 |
Unknown | 4 | 4 | 0 | Â |
ER status, n | Â | Â | Â | Â |
Positive | 67 | 70 | 23 | 64 |
Negative | 26 | 27 | 13 | 36 |
Unknown | 3 | 3 | 0 | Â |
Tumor recurrence, n | 31 | 32 | 19 | 53 |
Patient death, n | 52 | 53 | 14 | 39 |
Follow-up, years | Â | Â | Â | Â |
Median | 9.1 | Â | 6.8 | Â |
Range | 0.1-22 | Â | 0.6-10 | Â |